i6eal.de
DEEN
Start a project
← Back to the studies fieldPERMANENT CTIS TRIAL DOSSIER

2023-505430-10-00

TAP-TAU

Public registry stateAuthorised
CLAIM BOUNDARY

This dossier documents a medicinal trial—not proof of efficacy.

Registration, authorisation of a trial application, trial start, result disclosure and marketing authorisation are different facts. The dossier claims neither clinical efficacy nor safety, deployment or causality.

CTIS record ≠ efficacy ≠ marketing authorisation
REGISTRY FACTS

What CTIS publishes about this trial

EUCT number
2023-505430-10-00
Trial status
Authorised
Sponsor
not published
Trial region
EEA
Phase
10
Trial category
2
Low-intervention trial
no
Estimated EU start
10 October 2024
Decision date
21 December 2023
Published
19 March 2026
Estimated end
01 December 2026
EXACT AI EVIDENCE

The original text determines inclusion.

Terms count only in allowlisted public CTIS fields. Sponsor, medical condition, phase or a generic software reference alone is not AI evidence.

“Performance of tau PET compared to novel blood-based biomarkers and artificial intelligence (AI) based classifiers.”
Source field
authorizedApplication.authorizedPartI.trialDetails.trialInformation.endPoint.secondaryEndPoints[0].endPoint
Matched term
artificial intelligence
MEDICAL CONTEXT

Conditions and therapeutic areas

Reported medical conditions

  • Mild cognitive impairment and dementia

Therapeutic areas

  • Diseases [C] - Nervous System Diseases [C10]10
COUNTRY TRACKS

Every country retains its own published state.

A status in one country is not transferred to another. Decision dates and status histories remain separate source facts.

Netherlands

Authorised
First decision
21 December 2023
Latest decision
18 March 2026
  1. Authorised
  2. Authorised
  3. Authorised
  4. Authorised
  5. Authorised
  6. Authorised
  7. Authorised
TRIAL APPLICATIONS

Submission, decision and country state remain separate

IN

INITIAL

Authorised
Trial status
Authorised
Submitted
12 September 2023
Decided
21 December 2023

Decisions21 December 2023 · Authorized Conditions

Country statusNetherlands · Authorised

SM-1

SUBSTANTIAL MODIFICATION

Authorised
Trial status
Authorised
Submitted
08 July 2024
Decided
06 September 2024

Decisions06 September 2024 · Authorized

SM-2

SUBSTANTIAL MODIFICATION

Authorised
Trial status
Authorised
Submitted
29 January 2025
Decided
08 April 2025

Decisions08 April 2025 · Authorized

Country statusNetherlands · Authorised

SM-4

SUBSTANTIAL MODIFICATION

Authorised
Trial status
Authorised
Submitted
06 March 2026
Decided
18 March 2026

Decisions18 March 2026 · Authorized

Country statusNetherlands · Authorised

SOURCE-DATED CHRONICLE

Official dates, not an efficacy narrative.

The chronicle sorts published CTIS events. i6eal observation times follow on a separate clock.

  1. Application Submitted

    Application IN · Authorised

  2. Application Status

    Application IN · Authorised

  3. Country Assessment

    Netherlands · Application IN · Authorized Conditions

  4. Country Decision

    Netherlands · Application IN · Authorized Conditions

  5. Application Submitted

    Application SM-1 · Authorised

  6. Application Status

    Application SM-1 · Authorised

  7. Country Decision

    Netherlands · Application SM-1 · Authorized

  8. Application Submitted

    Application SM-2 · Authorised

  9. Application Status

    Application SM-2 · Authorised

  10. Country Assessment

    Netherlands · Application SM-2 · Authorized Conditions

  11. Country Decision

    Netherlands · Application SM-2 · Authorized

  12. Application Submitted

    Application SM-4 · Authorised

  13. Application Status

    Application SM-4 · Authorised

  14. Country Assessment

    Netherlands · Application SM-4 · Authorized Conditions

  15. Country Decision

    Netherlands · Application SM-4 · Authorized

  16. Trial Status Observed

    Authorised

Observed by i6eal
First observed
23 Jul 2026, 13:19
Last observed
23 Jul 2026, 15:03
Materially modified
23 July 2026
RESULT DISCLOSURE

Disclosure is a separate registry fact.

No result disclosure is published in this projection. This means neither that results do not exist nor that a deadline has been missed.

PROVENANCE

From the dossier back to the official record

The public CTIS record remains authoritative. The i6eal files are a deterministic, bounded projection.

Open public CTIS record ↗Open CTIS retrieval source ↗Machine-readable dossier · JSON ↓Structured metadata · JSON-LD ↓
i6eal (2026): EU AI Studies Monitor, CTIS trial 2023-505430-10-00, data state 23 July 2026. https://i6eal.de/en/tools/ki-studienmonitor/studie/2023-505430-10-00/
Related tools

Useful next steps

These tools complement the current result.

View all tools
MonitorEU AI medical-device lifecycle monitorWhich medical devices name AI explicitly? Inspect exact text evidence in the official EUDAMED software corpus by manufacturer, risk class, version and registry status—without inferring AI or conformity from software alone.IndexAI innovation pathFollow evidence-backed links from EU funding to reported research outputs—and see exactly where patents or procurement cannot yet be joined safely.IndexAI knowledge flowWhere does knowledge from publicly funded AI projects travel? Follow exact DOI links to citing works, countries, sectors and institutions, with coverage stated explicitly.